Filing Details
- Accession Number:
- 0001048477-24-000010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-12 17:20:05
- Reporting Period:
- 2024-01-18
- Accepted Time:
- 2024-02-12 17:20:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221590 | Jacques Jean Bienaime | C/O Biomarin Pharmaceutical Inc. 770 Lindaro Street San Rafael CA 94901 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-01-18 | 40 | $92.60 | 419,602 | No | 4 | L | Direct | |
| Common Stock | Acquisiton | 2024-02-08 | 15,000 | $63.10 | 434,602 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-08 | 15,000 | $89.77 | 419,602 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-09 | 15,000 | $63.10 | 434,602 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-09 | 15,000 | $88.28 | 419,602 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | L | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy Common Stock) | Disposition | 2024-02-08 | 15,000 | $0.00 | 15,000 | $63.10 |
| Common Stock | Stock Option (Right to Buy Common Stock) | Disposition | 2024-02-09 | 15,000 | $0.00 | 15,000 | $63.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 146,000 | 2014-12-04 | 2024-06-03 | No | 4 | M | Direct |
| 131,000 | 2014-12-04 | 2024-06-03 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 247,333 | Indirect | Shares held by Jean-Jacques Bienaime Family Trust |
| Common Stock | 100 | Indirect | Shares held as UTMA custodian for child 1 |
| Common Stock | 100 | Indirect | Shares held as UTMA custodian for child 2 |
Footnotes
- The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 40 shares, with the reporting person's sale of shares at a price of $98.19 on January 9, 2024. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.
- The price in column 4 is the weighted average price. The purchase price actually paid ranged from $92.595 to $92.60. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.
- Reflects the number of options outstanding after the transactions from this specific stock option grant.
Billionaire Hedge Funds
